Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
Authors:
Open Access
- 17 April 1998
- journal article
- predictive oncology
- Published by Wiley in International Journal of Cancer
- Vol. 79 (2) , 179-186
Abstract
To evaluate the association among known angiogenic growth factors or factors related to the plasminogen activation system and clinicopathological factors in patients with colorectal cancer, we examined the expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), transforming growth factor‐α (TGF‐α), urokinase‐type plasminogen activator (u‐PA), u‐PA receptor (u‐PA‐R) and plasminogen activator inhibitor‐1 (PAI‐1) in clinical specimens of colorectal cancers by Northern blot analysis. In comparison with the expression of these angiogenesis‐related genes in 7 paired samples of colorectal cancers and the adjacent normal mucosa, VEGF mRNA level was significantly higher in the cancer tissues than in the adjacent normal mucosa (p < 0.05). We analyzed expression of these genes in 44 cases of primary colorectal cancers. Among the 3 angiogenic growth factors we examined, VEGF mRNA expression was significantly higher in the cancer tissues with blood vessel invasion or with lymphatic vessel invasion than in those without, respectively (p < 0.05). On the other hand, u‐PA‐R mRNA expression was significantly higher in the cancers with blood vessel invasion than in those without (p < 0.05). In addition, there was a correlation between the expression levels of VEGF and u‐PA‐R mRNA in the cancer tissues we have examined. Using immunohistochemistry, strong staining of VEGF or u‐PA‐R was observed in the cancer cells invading the microvessels. Our findings suggest that malignant transformation might accompany the upregulation of VEGF expression in colorectal cancers and that VEGF and u‐PA‐R might contribute cooperatively to increase angiogenesis around the tumor as well as the metastasis via microvessels. Int. J. Cancer (Pred. Oncol.) 79:179–186, 1998.Keywords
This publication has 26 references indexed in Scilit:
- Vascular endothelial growth factor expression in primary esophageal squamous cell carcinomaCancer, 1997
- Expression of tissue‐type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on matrigelJournal of Cellular Physiology, 1995
- Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.Journal of Clinical Investigation, 1993
- Prevention of metastasis by inhibition of the urokinase receptor.Proceedings of the National Academy of Sciences, 1993
- Microvessel quantitation and prognosis in invasive breast carcinomaHuman Pathology, 1992
- Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumoursEuropean Journal of Cancer and Clinical Oncology, 1991
- Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cellsBlood, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Plasminogen Activators, Tissue Degradation, and Cancer1985
- General rules for clinical and pathological studies on cancer of the colon, rectum and anusSurgery Today, 1983